{"title":"【発表】iPS細胞由来2製品の早期承認を厚労省が了承 世界初の実用化へ、心不全やパーキンソン病治療に期待","path":"/ponzu/page/201670","site":"https://matomedane.jp","atUri":"at://did:plc:552wkftgqi65oynlogd2xk3k/site.standard.document/3mf7mdwlmwt72","publishedAt":"2026-02-19T12:38:10.253Z"}